Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS

Summary

Single patient expanded access program to provide galinpepimut-S for eligible patients with AML or MDS who have no other treatment option.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications